{
    "nct_id": "NCT04815876",
    "official_title": "Randomized Trial Comparing Transperineal vs. Transrectal MRI-targeted Prostate Biopsy; Randomized Controlled Trial Assessing Transperineal Prostate Biopsy to Reduce Infection Complications",
    "inclusion_criteria": "* Active surveillance cohort: History of Grade Group 1 prostate cancer, first diagnosed ≤24 months prior to date of planned confirmatory biopsy and diagnostic biopsy was preceded by a multiparametric MRI of the prostate\n* Prior negative cohort: Clinical concern for the presence of prostate cancer as determined by the treating urologist and prior negative prostate biopsy performed ≤36 months prior to date of planned biopsy\n* Willingness to sign informed consent and adhere to the study protocol\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Acute prostatitis within the last 6 months\n* Current non-urologic bacterial infection requiring active treatment with antibiotics\n* Unfit to undergo prostate biopsy under local anesthesia\n* Prior definitive therapy for prostate cancer, such as radiation therapy or partial gland ablation\n* Contraindication to prostate MRI (claustrophobia, pacemaker, chronic kidney disease)",
    "miscellaneous_criteria": ""
}